Comparison of the efficacy and safety of the EXTREME regimen for treating recurrent or metastatic head and neck squamous cell carcinoma in older and younger adult patients.
Naoki FukudaMayu YunokawaYu FujiwaraXiaofei WangAkihiro OhmotoNaomi HayashiTetsuya UrasakiYasuyoshi SatoKenji NakanoMakiko OnoJunichi TomomatsuHiroki MitaniShunji TakahashiPublished in: Cancer reports (Hoboken, N.J.) (2020)
The EXTREME regimen with optimal dose modification is safe and effective for both older and younger adult patients with HNSCC. The GNRI can be an indicator to select the older adult patients who can get benefit from the EXTREME regimen.